RNA Covid vaccine was initially 'developed for oncology use and was already in phase 2'

3 Views

  • Thanks! Share it with your friends!

    You disliked this video. Thanks for the feedback!

admin
Published
A new treatment nearly halves the risk of disease progression or death from a less common form of breast cancer that hasn't seen major drug advances in over a decade, Results from the study, presented at the annual meeting of the American Society for Clinical Oncology and could soon establish a new first-line therapy for people with HER2-positive metastatic breast cancer. Meanwhile, researchers are combining RNA and AI to develop tailor-made vaccines to combat cancer. For a deeper understanding of new technological breakthroughs in medicine, FRANCE 24's François Picard welcomes Dr. Moez Benali (MD, PhD), Senior Medical Director at Fortrea. Dr Benali is a member of Fortrea's global medical team and currently heads Oncologues Sans Frontières.
#RNACancerVaccine #Oncology

???? Subscribe to France 24 now: https://f24.my/YTen
???? LIVE - Watch FRANCE 24 English 24/7 here: https://f24.my/YTliveEN

???? Read the latest International News and Top Stories: https://www.france24.com/en/

Like us on Facebook: https://f24.my/FBen
Follow us on X: https://f24.my/Xen
Bluesky: https://f24.my/BSen and Threads: https://f24.my/THen
Browse the news in pictures on Instagram: https://f24.my/IGen
Discover our TikTok videos: https://f24.my/TKen
Get the latest top stories on Telegram: https://f24.my/TGen
Category
Oncology
Be the first to comment

Up Next